TNFA (TNF Pharmaceuticals Inc.) Bozor qiymatining balans qiymatiga nisbati

TNF Pharmaceuticals dori vositalarini ishlab chiqishni optimallashtirish uchun raqamli protein modellashtirishga mo'ljallangan bioinformatika platformalarini joriy qilmoqda. Kitob qiymatiga nisbatan bozor baholovishining tarixi investorlarning ishonchini namoyish etadi, bunda 0.30 eng so'nggi metrika ko'rsatkichini ifodalaydi. Kompaniya klinik ma'lumotlar tahlili uchun dasturiy robotlarni joriy qilmoqda, shu bilan birga ishlab chiqarish jarayonida ekologik ta'sirni minimallashtirish uchun yopiq siklli suv tizimlariga o'tmoqda.

TNFA tnfpharma.com: Balans qiymatiga nisbatan bozor qiymati 25.07.2024 - 25.09.2025 oraligʻida

TNF Pharmaceuticals (TNFA) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi tnfpharma.com|TNFA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati TNF Pharma|TNFA - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati TNF Pharmaceuticals|TNFA - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati tnfpharma.com|TNFA - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati TNF Pharmaceuticals|TNFA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati tnfpharma.com|TNFA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar TNF Pharma|TNFA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari TNF Pharmaceuticals
Kompaniyaning dastlabki tahlili:TNF Pharmaceuticals Inc. - TNFA

TNF Pharmaceuticals (TNFA) uchun ushbu koeffitsient B2B sherikliklar orqali molekulani tasdiqlash davridagi aktivlarning bozor qiymatini aks ettiradi. Ushbu metrika investitsiya premiumini o'lchash uchun kompaniyaning joriy bozor qiymatini uning sof balans qiymati bilan solishtiradi. Narxning balans qiymatiga nisbati (P/BV) tendentsiyasi bozor pipeline'ning kelajakdagi salohiyati uchun qanchalik premium to'lashga tayyor ekanligini ko'rsatadi. Ushbu ko'rsatkichdagi keskin og'ishlar yo spekulyativ qizib ketishni, yoki past baholanganlikni signalizatsiya qilib, emitentning moddiy aktivlariga nisbatan kapitalizatsiya barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

HLN: Bozor kapitallashuvining balans qiymatiga nisbati|KVUE (kenvue.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati enterabio.com ENTX|Kapitallashuvning sof aktivlarga nisbati MindWalk Holdings Inc. (HYFT)|ABVC BioPharma Inc. - Bozor kapitallashuvining balans qiymatiga multiplikatori|Cumberland Pharma (CPIX) - Bozor qiymatining balans qiymatiga nisbati|QNTM - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati FibroGen, Inc. (FGEN)|Sof aktivlarga nisbatan bozor kapitallashuvi telomirpharma.com|RANI - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati SNYR|RLYB - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi lexariabioscience.com (LEXX)|Bozor kapitallashuvining balans qiymatiga nisbati Pulmatrix, Inc.|Balans qiymatiga nisbatan bozor qiymati Pheton Holdings Limited PTHL|Aptorum - Bozor kapitallashuvining balans qiymatiga nisbati|LYRA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Impact BioMedical IBO|YCBD (cbdMD) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati PRFX|Kapitallashuvning sof aktivlarga nisbati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO|Bozor kapitallashuvining balans qiymatiga nisbati OptiNose Inc (OPTN)|Pieris - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Procaps Group Corp PROC|PTPI (Petros Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|qlsyy.net (QLI) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SLRN: Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TFF Pharmaceuticals Inc.